Jan 2026· Human Mutation· Vol 2026· 0 citations· 38 references
Medicine
TL;DR
The present case contributes a homozygous splice‐site variant with experimentally confirmed aberrant splicing and an in‐frame protein alteration in titin, providing additional case‐level and functional evidence for a possible role of specific TTN splicing defects in HCM.
Abstract
The TTN gene encodes a crucial structural protein within cardiac sarcomeres, and its variants may contribute to hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy; however, phenotype and genotype are different. Whole‐exome sequencing (WES) was conducted on a Chinese proband diagnosed with HCM. In silico splicing prediction tools and minigene assays were employed to investigate the impact of the identified variant on mRNA splicing. A literature review was performed to retrieve and analyze previously reported splicing variants in the TTN gene associated with HCM. A 42‐year‐old male proband presented with nonobstructive HCM and paroxysmal atrial arrhythmias. A novel homozygous TTN variant was found, predicted to cause a 14‐base pair deletion at a splice acceptor site. Two asymptomatic offspring were found to carry the heterozygous variant. Based on variant interpretation guidelines, the variant met the PM2_supporting criterion and was classified as a variant of uncertain significance (VUS). The predicted aberrant splicing effect was subsequently confirmed by the minigene splicing assay, demonstrating altered pre‐mRNA splicing leading to an in‐frame insertion/deletion (p.Arg32498_Glu32504delinsGln). Functional verification confirmed that this mutation conforms to the PM4 criterion, suggesting that it can be reclassified as a tepid VUS (scoring 3 points). The functional result might provide pathogenic evidence. We also reviewed 28 previously reported splicing variants in TTN associated with HCM. Of these, 57.1% (16/28) localized to the I‐band region, whereas 21.4% (6/28) were situated in the A‐band domain of titin. Notably, 21.4% (6/28) co‐occurred with pathogenic variants in other sarcomeric genes (MYH7 or MYBPC3), correlating with more severe clinical phenotypes. Reclassification and reinterpretation of the variants revealed that none met the level of likely pathogenic or higher. The present case contributes a homozygous splice‐site variant with experimentally confirmed aberrant splicing and an in‐frame protein alteration in titin. The focus of this report is the Mendelian genetic basis of the proband′s cardiomyopathy phenotype, and our data provide additional case‐level and functional evidence for a possible role of specific TTN splicing defects in HCM.
BACKGROUND: Disruption of MYBPC3 precursor mRNA splicing is a frequent genetic cause of hypertrophic cardiomyopathy (HCM). Most often, it reflects changes at canonical sites or the creation of novel splice sites. Prediction tools usually prioritize splice variants with lower efficiency when they are distant from canoni...
M. Gallego-Delgado, S. L. Lorenzo Hernández, Soledad García Hernández et al.· Circulation· 0 citations
It is demonstrated that some cryptic donor–acceptor motif pairings are likely incompatible with splicing, which may inform future improvements in in silico splice site prediction tools.
E. Singer, Serena Li, Ginell N. Ranpura et al.· Human Mutation· 0 citations
Background: Joubert syndrome (JS) is a genetically heterogeneous ciliopathy wherein non-canonical splice-site (NCSS) variants are frequently reported as variants of uncertain significance (VUS), complicating prenatal counseling. We aimed to clarify the clinical significance of an NCSS in CC2D2A through functional valid...
Fang Wang, Jia-Ying Zhang, Chao Lu et al.· Diagnostics· 0 citations
Findings demonstrate that c.5273A>G functions as a LoF variant through dual aberrant splicing rather than a simple missense substitution, which underscores the importance of RNA-level splicing analysis for the accurate interpretation and classification of CHD7 missense variants.
Takashi Okuno, Tatsuto Shimizu, Aiko Igarashi et al.· American Journal of Medical...· 0 citations
OBJECTIVES
CHARGE syndrome (CS), a rare inherited condition, is mainly caused by pathogenic variants in the gene encoding chromodomain helicase DNA-binding protein 7 (CHD7). In the present investigation, the genetic etiology of CS was elucidated in a Chinese patient presenting with characteristic clinical features.
M...
Yen Fei, D. Hu, Lyu Liu et al.· American journal of translat...· 0 citations
Established genomic and population-level evidence support a Likely Pathogenic, loss-of-function classification for the TTN p.Arg3936Ter variant, which introduces a premature termination codon predicted to generate a truncated titin protein of 3,935 amino acids and is predicted to escape nonsense-mediated decay.
Lydier De Gracia, O. Espinosa, L. Sotillo et al.· Gene Clin Genom· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.